◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Karnalyte Resources Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 301,000 371,000 309,000 337,000 341,000 --
General And Administrative Expense 301,000 371,000 309,000 337,000 341,000 --
Depreciation And Amortization In Income Statement 3,000 3,000 3,000 3,000 3,000 --
Operating Expense 304,000 374,000 312,000 340,000 344,000 --
Operating Income -304,000 -374,000 -312,000 -340,000 -344,000 --
EBIT -494,000 523,000 -551,000 -382,000 -254,000 --
Interest Expense 15,000 12,000 13,000 10,000 13,000 --
Interest Expense Non Operating 15,000 12,000 13,000 10,000 13,000 --
Interest Income 8,000 8,000 6,000 8,000 12,000 --
Interest Income Non Operating 8,000 8,000 6,000 8,000 12,000 --
Net Interest Income -7,000 -4,000 -7,000 -2,000 -1,000 --
Other Income Expense -198,000 889,000 -245,000 -50,000 78,000 --
Other Non Operating Income Expenses 6,000 62,000 -- 199,000 8,000 27,000
Special Income Charges -204,000 827,000 -245,000 -249,000 70,000 --
Pretax Income -509,000 511,000 -564,000 -392,000 -267,000 --
Tax Effect Of Unusual Items 0.00 124,050 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -509,000 511,000 -564,000 -392,000 -267,000 --
Net Income From Continuing Operation Net Minority Interest -509,000 511,000 -564,000 -392,000 -267,000 --
Net Income Including Noncontrolling Interests -509,000 511,000 -564,000 -392,000 -267,000 --
Net Income Common Stockholders -509,000 511,000 -564,000 -392,000 -267,000 --
Net Income -509,000 511,000 -564,000 -392,000 -267,000 --
EBITDA -490,000 526,000 -548,000 -379,000 -251,000 --
Normalized EBITDA -286,000 -301,000 -303,000 -130,000 -321,000 --
Reconciled Depreciation 4,000 3,000 3,000 3,000 3,000 --
Basic EPS -0.01 0.01 -0.01 -- -0.01 -0.01
Diluted EPS -0.01 0.01 -0.01 -- -0.01 -0.01
Basic Average Shares 53.3M 53.3M 53.3M -- 53.3M 53.3M
Diluted Average Shares 53.3M 54.2M 53.3M -- 53.3M 53.3M
Total Unusual Items -204,000 827,000 -245,000 -249,000 70,000 --
Total Unusual Items Excluding Goodwill -204,000 827,000 -245,000 -249,000 70,000 --
Tax Rate For Calcs 0.00 0.15 0.00 0.00 0.00 --
Normalized Income -305,000 -191,950 -319,000 -143,000 -337,000 --
Depreciation Amortization Depletion Income Statement 3,000 3,000 3,000 3,000 3,000 --
Depreciation Income Statement 3,000 3,000 3,000 3,000 3,000 --
Diluted NI Availto Com Stockholders -509,000 511,000 -564,000 -392,000 -267,000 --
Gain On Sale Of Ppe 0.00 988,000 -- 0.00 261,000 0.00
Impairment Of Capital Assets 204,000 161,000 245,000 249,000 191,000 --
Net Income Continuous Operations -509,000 511,000 -564,000 -392,000 -267,000 --
Net Non Operating Interest Income Expense -7,000 -4,000 -7,000 -2,000 -1,000 --
Other Gand A 289,000 367,000 304,000 64,000 330,000 --
Salaries And Wages 12,000 4,000 5,000 273,000 11,000 --
Total Expenses 304,000 374,000 312,000 340,000 344,000 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 605,000 1.1M 498,000 870,000 1.0M --
Cash Cash Equivalents And Short Term Investments 605,000 1.1M 498,000 870,000 1.0M --
Accounts Receivable 69,000 76,000 74,000 61,000 76,000 --
Receivables 69,000 76,000 74,000 61,000 76,000 --
Prepaid Assets 401,000 433,000 472,000 294,000 437,000 --
Current Assets 1.1M 1.6M 1.5M 1.2M 1.5M --
Gross PPE 76.2M 76.0M 75.8M 76.0M 75.7M --
Accumulated Depreciation -71.3M -71.1M -71.0M -70.7M -70.5M --
Net PPE 4.8M 4.8M 4.9M 5.3M 5.3M --
Goodwill And Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 --
Other Non Current Assets 375,000 375,000 375,000 375,000 375,000 --
Total Non Current Assets 5.2M 5.2M 5.2M 5.7M 5.7M --
Total Assets 6.3M 6.8M 6.7M 6.9M 7.2M --
Accounts Payable 451,000 682,000 1.1M 721,000 655,000 --
Payables 682,000 682,000 1.1M 721,000 655,000 --
Payables And Accrued Expenses 682,000 682,000 1.1M 721,000 655,000 --
Other Current Liabilities 1.6M 1.6M 1.6M -- -- --
Current Liabilities 2.3M 2.2M 2.7M 721,000 655,000 --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 1.3M 1.3M --
Total Liabilities Net Minority Interest 2.3M 2.2M 2.7M 2.0M 1.9M --
Common Stock 136.0M 136.0M 136.0M 136.0M 136.0M --
Capital Stock 136.0M 136.0M 136.0M 136.0M 136.0M --
Additional Paid In Capital 9.8M 9.8M 9.8M 9.8M 9.8M --
Retained Earnings -141.7M -141.2M -141.7M -140.9M -140.5M --
Common Stock Equity 4.0M 4.5M 4.0M 4.9M 5.2M --
Stockholders Equity 4.0M 4.5M 4.0M 4.9M 5.2M --
Total Equity Gross Minority Interest 4.0M 4.5M 4.0M 4.9M 5.2M --
Total Capitalization 4.0M 4.5M 4.0M 4.9M 5.2M --
Net Tangible Assets 4.0M 4.5M 4.0M 4.9M 5.2M --
Tangible Book Value 4.0M 4.5M 4.0M 4.9M 5.2M --
Working Capital -1.2M -685,000 -1.2M 504,000 882,000 --
Invested Capital 4.0M 4.5M 4.0M 4.9M 5.2M --
Share Issued 53.3M 53.3M 53.3M 53.3M 53.3M --
Ordinary Shares Number 53.3M 53.3M 53.3M 53.3M 53.3M --
Assets Held For Sale Current -- -- 420,000 -- -- --
Construction In Progress 20.0M 20.0M 20.0M 20.0M 20.0M --
Current Provisions -- -- 1.6M -- -- --
Long Term Provisions -- -- -- 1.3M 1.3M 1.3M
Other Payable 231,000 -- -- -- -- --
Other Properties 1.7M 1.7M 1.7M 1.7M 1.7M --
Properties 54.5M 54.3M 54.1M 54.3M 54.1M --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -243,000 -669,000 -150,000 95,000 -210,000 --
Cash Flow From Continuing Operating Activities -243,000 -669,000 -150,000 95,000 -210,000 --
Depreciation And Amortization 4,000 3,000 3,000 3,000 3,000 --
Depreciation Amortization Depletion 4,000 3,000 3,000 3,000 3,000 --
Stock Based Compensation 11,000 4,000 5,000 9,000 11,000 --
Change In Working Capital -198,000 -338,000 149,000 225,000 100,000 --
Change In Receivables 1,000 1,000 -12,000 16,000 -3,000 --
Change In Payables And Accrued Expense -231,000 -378,000 339,000 66,000 46,000 --
Change In Payable -231,000 -378,000 339,000 66,000 46,000 --
Other Non Cash Items 231,000 -27,000 7,000 -6,000 -9,000 --
Capital Expenditure -205,000 -184,000 -222,000 -249,000 -191,000 --
Purchase Of PPE -205,000 -184,000 -222,000 -249,000 -191,000 --
Net PPE Purchase And Sale -205,000 1.2M -222,000 -249,000 70,000 --
Investing Cash Flow -205,000 1.2M -222,000 -249,000 70,000 --
Cash Flow From Continuing Investing Activities -205,000 1.2M -222,000 -249,000 70,000 --
Effect Of Exchange Rate Changes -- -- -- 0.00 0.00 0.00
Changes In Cash -448,000 555,000 -372,000 -154,000 -140,000 --
Beginning Cash Position 1.1M 498,000 870,000 1.0M 1.2M --
End Cash Position 605,000 1.1M 498,000 870,000 1.0M --
Free Cash Flow -448,000 -853,000 -372,000 -154,000 -401,000 --
Asset Impairment Charge 205,000 161,000 245,000 249,000 191,000 --
Change In Prepaid Assets 32,000 39,000 -178,000 143,000 57,000 --
Depreciation 4,000 3,000 3,000 3,000 3,000 --
Gain Loss On Sale Of PPE 0.00 -- -- 0.00 -261,000 --
Interest Received Cfo 14,000 5,000 5,000 7,000 21,000 --
Net Income From Continuing Operations -510,000 511,000 -564,000 -392,000 -266,000 --
Operating Gains Losses 0.00 -- -- 0.00 -- --
Sale Of PPE 0.00 -- -- 0.00 261,000 --
NEWS
Loading news...
TRENDING
Loading...